User:Mr. Ibrahem/Decitabine/cedazuridine

Decitabine/cedazuridine, sold under the brand name Inqovi, is a combination medication used to treat myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML). It is taken by mouth.

Common side effects include tiredness, constipation, bleeding, muscle pain, mouth sores, nausea, shortness of breath, rash, swelling, pneumonia, and liver problems. Other side effects may include bone marrow suppression and infertility. Use in pregnancy may harm the baby. Decitabine is a nucleoside metabolic inhibitor and cedazuridine is a cytidine deaminase inhibitor.

The combination was approved for medical use in the United States and in Canada in 2020. In the United States the cost every four weeks is about 7,800 USD as of 2021.